{
    "clinical_study": {
        "@rank": "14820", 
        "acronym": "RECEL", 
        "arm_group": [
            {
                "arm_group_label": "Erlotinib w Concurrent Radiotherapy", 
                "arm_group_type": "Experimental", 
                "description": "erlotinib 150mg oral daily up to 2 years concurrent radiotherapy total dose 60-66 Gray (Gy) in 2 Gray (Gy) fractions. One fraction per day, and 5 fractions per week."
            }, 
            {
                "arm_group_label": "etoposide/cis-platin (EP) w Concurrent Radiotherapy", 
                "arm_group_type": "Active Comparator", 
                "description": "etoposide 50mg/m2 on D1-5 and D29-33 cis-platin 50mg/m2 on D1, D8, D29 and D36 concurrent radiotherapy total 60-66 Gray (Gy) in 2 Gray (Gy) fractions. One fraction per day, 5 fractions per week."
            }
        ], 
        "brief_summary": {
            "textblock": "Erlotinib with concurrent radiotherapy  has superior efficacy and comparable safety profile\n      in unresectable stage III non-small cell lung cancer (NSCLC) patients with activating\n      mutation of epidermal growth factor receptor (EGFR) in exon 19 or 21 versus etoposide plus\n      cis-platin with concurrent radiotherapy."
        }, 
        "brief_title": "Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Non-small Cell Lung Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  NSCLC confirmed by histopathology or cytology;\n\n          -  Stage IIA or IIIB NSCLC according to Tumor Node Metastasis (TMN) staging of Lung\n             Staging Standard version 7 2009, and be unresectable;\n\n          -  Has active mutation of EGFR in exon 19 or 21;\n\n          -  Has measurable lesion [according to Response Evaluation Criteria in Solid Tumors\n             (RECIST) 1.1, must have at least one evaluable lesion with the longest dimension >=\n             10mm; if the evaluable lesion is lymph node, the shortest dimension should be\n             measured and >=15mm];\n\n          -  Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1;\n\n          -  expectancy life >= 12 weeks;\n\n        Exclusion Criteria:\n\n          -  Had be treated by HER-targeting agents;\n\n          -  Had systemic anit-NSCLC treatments;\n\n          -  Had local radiotherapy for NSCLC;\n\n          -  Has upper gastrointestinal physiological disorders, or malabsorption syndrome, or\n             intolerance of oral medication, or active peptic ulcer;\n\n          -  Diagnosed other malignant tumor besides NSCLC within 5 years prior the study\n             treatment (except having simple surgical resection with 5-year disease free survival,\n             cured in situ of cervical carcinoma, cured basal cell carcinoma and bladder\n             epithelial tumor);\n\n          -  Any evidence to indicate moderate or severe chronic obstructive pulmonary disease\n             (COPD);\n\n          -  Known hypersensitivity to platinum, etoposide, EGFR-Tyrosine Kinase Inhibitor (TKI)\n             agents or relevant components in the formulation;\n\n          -  Uncontrolled eye inflammation or infection, or any potential circumstances lead to\n             eye inflammation or infection;"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01714908", 
            "org_study_id": "ML28545"
        }, 
        "intervention": [
            {
                "arm_group_label": "Erlotinib w Concurrent Radiotherapy", 
                "intervention_name": "Erlotinib w Concurrent Radiotherapy", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "etoposide/cis-platin (EP) w Concurrent Radiotherapy", 
                "description": "Etoposide / Cis-platin w Concurrent Radiotherapy", 
                "intervention_name": "etoposide/cis-platin (EP) w Concurrent Radiotherapy", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Etoposide phosphate", 
                "Cisplatin", 
                "Etoposide", 
                "Erlotinib"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "NSCLC", 
            "EGFR mutation", 
            "unresectable", 
            "erlotinib", 
            "concurrent radiotherapy"
        ], 
        "lastchanged_date": "October 26, 2012", 
        "location": [
            {
                "contact": {
                    "email": "wlhwq@yahoo.com", 
                    "last_name": "Lvhua Wang, PhD", 
                    "phone": "8613601283715"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100021"
                    }, 
                    "name": "Cancer Institute & Hospital, Chinese Academy of Medical Sciences"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "zgypu@yahoo.com.cn", 
                    "last_name": "Guangying Zhu, PhD", 
                    "phone": "8613717999977"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100142"
                    }, 
                    "name": "Beijing Cancer Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "68434886@163.com", 
                    "last_name": "Tingyi Xia, PhD", 
                    "phone": "8613901380726"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100853"
                    }, 
                    "name": "Chinese PLA General Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jianchengli6@126.com", 
                    "last_name": "Jiancheng Li, PhD", 
                    "phone": "8613906900190"
                }, 
                "facility": {
                    "address": {
                        "city": "Fuzhou", 
                        "country": "China", 
                        "state": "Fujian", 
                        "zip": "350008"
                    }, 
                    "name": "Fujian Province Cancer Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "hanchun2006@yahoo.com.cn", 
                    "last_name": "Chun Han, PhD", 
                    "phone": "8613831105846"
                }, 
                "facility": {
                    "address": {
                        "city": "Shijiazhuang", 
                        "country": "China", 
                        "state": "Hebei", 
                        "zip": "050011"
                    }, 
                    "name": "Hebei Medical University Fourth Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "jianhua@371.net", 
                    "last_name": "Jianhua Wang, PhD", 
                    "phone": "8613938278827"
                }, 
                "facility": {
                    "address": {
                        "city": "Zhengzhou", 
                        "country": "China", 
                        "state": "Henan", 
                        "zip": "450008"
                    }, 
                    "name": "Henan Cancer Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "Chxie_65@hotmail.com", 
                    "last_name": "Conghua Xie, PhD", 
                    "phone": "8613638607566"
                }, 
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China", 
                        "state": "Hubei", 
                        "zip": "430030"
                    }, 
                    "name": "Zhongnan Hospital of Wuhan University"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "wugangzr@yahoo.com.cn", 
                    "last_name": "Gang Wu, PhD", 
                    "phone": "8613871240042"
                }, 
                "facility": {
                    "address": {
                        "city": "Wuhan", 
                        "country": "China", 
                        "state": "Hubei", 
                        "zip": "430022"
                    }, 
                    "name": "Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "liguang1963@yahoo.com.cn", 
                    "last_name": "Guang Li, PhD", 
                    "phone": "8613804058616"
                }, 
                "facility": {
                    "address": {
                        "city": "Shenyang", 
                        "country": "China", 
                        "state": "Liaoning", 
                        "zip": "110001"
                    }, 
                    "name": "The First Hospital of China Medical University"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "xinglg@gmail.com", 
                    "last_name": "Ligang Xing, PhD", 
                    "phone": "8653167626819"
                }, 
                "facility": {
                    "address": {
                        "city": "Jinan", 
                        "country": "China", 
                        "state": "Shandong", 
                        "zip": "250117"
                    }, 
                    "name": "Shandong Cancer Hospital and Institute"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "xlfu1964@126.com", 
                    "last_name": "Xiaolong Fu, PhD", 
                    "phone": "8613651635103"
                }, 
                "facility": {
                    "address": {
                        "city": "Shanghai", 
                        "country": "China", 
                        "state": "Shanghai", 
                        "zip": "200032"
                    }, 
                    "name": "Fudan University Shanghai Cancer Center"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "radyoulu@hotmail.com", 
                    "last_name": "You Lu, PhD", 
                    "phone": "8613981935716"
                }, 
                "facility": {
                    "address": {
                        "city": "Chengdu", 
                        "country": "China", 
                        "state": "Sichuan", 
                        "zip": "610041"
                    }, 
                    "name": "West China Hospital, West China School of Medicine, Sichuan University"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tianjin", 
                        "country": "China", 
                        "state": "Tianjin", 
                        "zip": "300060"
                    }, 
                    "name": "Tianjin Medical University Cancer Institute and Hospital"
                }
            }, 
            {
                "contact": {
                    "email": "mashenglin@medmail.com.cn", 
                    "last_name": "Shenglin Ma, PhD", 
                    "phone": "8613588799118"
                }, 
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China", 
                        "state": "Zhejiang", 
                        "zip": "310006"
                    }, 
                    "name": "The First People's Hospital of Hangzhou"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "chenming@sysucc.org.cn", 
                    "last_name": "Ming Chen, PhD", 
                    "phone": "8613609020845"
                }, 
                "facility": {
                    "address": {
                        "city": "Hangzhou", 
                        "country": "China", 
                        "state": "Zhejiang", 
                        "zip": "310022"
                    }, 
                    "name": "Zhejiang Cancer Hospital"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Multicenter, Randomized, Open-label, Phase II Study to Evaluate the Efficacy and Safety of Erlotinib Versus Etoposide Plus Cisplatin With Concurrent Radiotherapy in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) With Activating Mutation of Epidermal Growth Factor Receptor (EGFR) in Exon 19 or 21", 
        "overall_contact": {
            "email": "song.lu@fountain-med.com", 
            "last_name": "Song Lu, Bachelor", 
            "phone": "862151088628", 
            "phone_ext": "8005"
        }, 
        "overall_contact_backup": {
            "email": "cong.cheng@fountain-med.com", 
            "last_name": "Cong Cheng, Bachelor", 
            "phone": "862151088628", 
            "phone_ext": "8013"
        }, 
        "overall_official": [
            {
                "affiliation": "Shandong Cancer Hospital and Institute", 
                "last_name": "Jinming Yu, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "The First People's Hospital of Hangzhou", 
                "last_name": "Shenglin Ma, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Wuhan University", 
                "last_name": "Conghua Xie, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Zhejiang Cancer Hospital", 
                "last_name": "Ming Chen, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Tongji Medical College, Huazhong University of Science and Technology, Wuhan Union Hospital", 
                "last_name": "Gang Wu, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Henan Cancer Hospital", 
                "last_name": "Jianhua Wang, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Fujian Province Cancer Hospital", 
                "last_name": "Jiancheng Li, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Fudan University", 
                "last_name": "Xiaolong Fu, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "West China Hospital, West China School of Medicine, Sichuan University", 
                "last_name": "You Lu, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Cancer Institute Hospital, Chinese Academy of Medical Sciences", 
                "last_name": "Lvhua Wang, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Beijing Cancer Hospital", 
                "last_name": "Guangying Zhu, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Chinese PLA General Hospital", 
                "last_name": "Tingyi Xia, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hebei Medical University Fourth Hospital", 
                "last_name": "Chun Han, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "China Medical University, China", 
                "last_name": "Guang Li, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Tianjin Medical University Cancer Institute and Hospital", 
                "last_name": "Zhiyong Yuan, PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The time frame from the randomization to the first confirmed disease progression or any cause to death (dependent on which comes first)", 
            "measure": "Progress Free Survival (PFS)", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01714908"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shandong Cancer Hospital and Institute", 
            "investigator_full_name": "Jinming Yu", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Shandong Cancer Hospital and Institute", 
        "sponsors": {
            "collaborator": {
                "agency": "Roche Pharma AG", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Jinming Yu", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}